New oral drug to control immediate rise in blood glucose levels and how it works

By: |
November 17, 2021 1:43 PM

The oral drug developed by Tarek Fahmy, Associate Professor of Biomedical Engineering, Yale University is a much simpler treatment for diabetes patients than insulin or other standard remedies

dibetes oral drug, diabetes treatment, control immediate rise in blood glucose levels, Tarek Fahmy, Associate Professor of Biomedical Engineering, Yale University, re-instating normal metabolismAn oral medication that can replace insulin injection and control blood sugar level while reversing the inflammatory effects of the pancreas at the same time

Human insulin shots are used in Type 1 diabetes patients to control blood sugar, a condition in which the body cannot make insulin, or in type 2 diabetes patients in which blood sugar is so high that the body cannot use insulin normally. Researchers at Yale University, now, has come up with an oral medication that can replace insulin injection and control blood sugar level while reversing the inflammatory effects of the pancreas at the same time.

The oral drug developed by Tarek Fahmy, Associate Professor of Biomedical Engineering, Yale University is a much simpler treatment for diabetes patients than insulin or other standard remedy and targets three major issues i.e control immediate blood glucose level, re-establish normal immunity, and restores pancreatic functions.

This is achieved through a nanocarrier made of naturally produced body fluids like bile acids. The carrier works with the loaded agents causing therapeutic effects and re-instating normal metabolism in the short-term and immune competence in the long term. The nanocarrier approach system is a promising new therapy for autoimmune diseases in general.

The new drug eliminates the chances of it breaking down in a patient’s gastrointestinal system due to its carrier nanoparticle and hence safely takes the insulin to the pancreas where it unloads. The nanoparticle is made from polymerised ursodeoxycholic acid, a bile acid that is used to make drugs by dissolving liver stones and gallstones but was not found much effective to treat Diabetes, the release said. But the new drug polymerised bile acids increasing its  ability to bind with receptors used for metabolism and making it more effective as a treatment for diabetes.

While treating it on animals, the nanoparticles reversed inflammation, restored metabolic functions, and extended its survival when the cargo of the particles restored insulin levels.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Delhi CM urges PM Modi to stop flights from countries affected by new Covid variant
2PM Modi to chair important meeting on Covid situation on Saturday
3World races to contain new COVID threat, the omicron variant